4.8 Article

Rare inherited kidney diseases: challenges, opportunities, and perspectives

期刊

LANCET
卷 383, 期 9931, 页码 1844-1859

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(14)60659-0

关键词

-

资金

  1. European Union [305608]
  2. Gebert-Ruf Stiftung [GRS-038/12]
  3. Cystinosis Research Foundation
  4. Swiss National Science Foundation [310030_146490]
  5. Klinischer Forschungsschwerpunkt (KFSP) radiz - Rare Disease Initiative Zurich
  6. National Centre of Competence in Research (NCCR) Kidney.CH
  7. Dutch Kidney Foundation (CP11.18 Project Kouncil)
  8. KfH Foundation for Preventive Medicine (4C Study)
  9. National Institutes of Health (PediGFR) [5R01DK082394-03]
  10. Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish
  11. Swiss National Science Foundation (SNF) [310030_146490] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

At least 10% of adults and nearly all children who receive renal-replacement therapy have an inherited kidney disease. These patients rarely die when their disease progresses and can remain alive for many years because of advances in organ-replacement therapy. However, these disorders substantially decrease their quality of life and have a large effect on health-care systems. Since the kidneys regulate essential homoeostatic processes,inherited kidney disorders have multisystem complications, which add to the usual challenges for rare disorders. In this review, we discuss the nature of rare inherited kidney diseases, the challenges they pose, and opportunities from technological advances, which are well suited to target the kidney. Mechanistic insights from rare disorders are relevant for common disorders such as hypertension, kidney stones, cardiovascular disease, and progression of chronic kidney disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据